Thanks for your glass is all empty thoughts. I too don’t trust the FDA but if it was one of the treatments already touted by government or one that’s gotten lots of media pretty much every other drug why hold a special press briefing for it like a big breakthrough surprise? This could be the reason it’s leronlimab besides all the Safety and Efficiency data and the fact that we are only ones with a request for EAU that I know as well as a completed phase 2 trial with a statistical NEWS endpoint met with a .023 pvalue.